Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:Corticosteroid |
| gptkbp:approvedBy |
1987
|
| gptkbp:ATCCode |
R01AD09
D07AC13 |
| gptkbp:brand |
gptkb:Asmanex
gptkb:Nasonex Elocon |
| gptkbp:CASNumber |
83919-23-7
|
| gptkbp:contraindication |
untreated bacterial infection
|
| gptkbp:developedBy |
gptkb:Schering-Plough
|
| gptkbp:eliminationHalfLife |
5.8 hours
|
| gptkbp:hasMolecularFormula |
C27H30Cl2O6
|
| https://www.w3.org/2000/01/rdf-schema#label |
mometasone
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
liver
|
| gptkbp:partOf |
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
topical
inhalation intranasal |
| gptkbp:sideEffect |
headache
cough sore throat skin irritation nosebleed |
| gptkbp:usedFor |
asthma
allergic rhinitis nasal polyps inflammatory skin conditions |
| gptkbp:bfsParent |
gptkb:formoterol
|
| gptkbp:bfsLayer |
6
|